Pancreatitis, very early compared with normal start of enteral feeding (PYTHON trial): design and rationale of a randomised controlled multicenter trial
Authors:
- Olaf J BakkerOBOlaf J Bakker
- Hjalmar C van SantvoortHSHjalmar C van Santvoort
- Sandra van BrunschotSBSandra van Brunschot
- Usama Ahmed AliUAUsama Ahmed Ali
- Marc G BesselinkMBMarc G Besselink
- Marja A BoermeesterMBMarja A Boermeester
- Thomas L BollenTBThomas L Bollen
- Koop BosschaKBKoop Bosscha
- Menno A BrinkMBMenno A Brink
- Cornelis H DejongCDCornelis H Dejong
- Erwin J van GeenenEGErwin J van Geenen
- Harry van GoorHGHarry van Goor
Open Access
- 10 March 2011
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 12 (1) , 73
Abstract
Background: In predicted severe acute pancreatitis, infections have a negative effect on clinical outcome. A start of enteral nutrition (EN) within 24 hours of onset may reduce the number of infections as compared to the current practice of starting an oral diet and EN if necessary at 3-4 days after admission. Methods/Design: The PYTHON trial is a randomised controlled, parallel-group, superiority multicenter trial. Patients with predicted severe acute pancreatitis (Imrie-score ≥ 3 or APACHE-II score ≥ 8 or CRP > 150 mg/L) will be randomised to EN within 24 hours or an oral diet and EN if necessary, after 72 hours after hospital admission. During a 3-year period, 208 patients will be enrolled from 20 hospitals of the Dutch Pancreatitis Study Group. The primary endpoint is a composite of mortality or infections (bacteraemia, infected pancreatic or peripancreatic necrosis, pneumonia) during hospital stay or within 6 months following randomisation. Secondary endpoints include other major morbidity (e.g. new onset organ failure, need for intervention), intolerance of enteral feeding and total costs from a societal perspective. Discussion: The PYTHON trial is designed to show that a very early (< 24 h) start of EN reduces the combined endpoint of mortality or infections as compared to the current practice of an oral diet and EN if necessary at around 72 hours after admission for predicted severe acute pancreatitis. Trial Registration: ISRCTN: ISRCTN18170985Keywords
This publication has 27 references indexed in Scilit:
- A Step-up Approach or Open Necrosectomy for Necrotizing PancreatitisNew England Journal of Medicine, 2010
- Timing and impact of infections in acute pancreatitisBritish Journal of Surgery, 2009
- The Impact of Hospital-Acquired Infection on Outcome in Acute PancreatitisGastroenterology, 2008
- Debridement and Closed Packing for Sterile or Infected Necrotizing PancreatitisAnnals of Surgery, 2008
- Prophylactic Antibiotics Cannot Reduce Infected Pancreatic Necrosis and Mortality in Acute Necrotizing Pancreatitis: Evidence From a Meta-Analysis of Randomized Controlled TrialsAmerican Journal of Gastroenterology, 2008
- Randomized Controlled Trials of Antibiotic Prophylaxis in Severe Acute Pancreatitis: Relationship between Methodological Quality and OutcomePancreatology, 2007
- Practice Guidelines in Acute PancreatitisAmerican Journal of Gastroenterology, 2006
- Bacterial translocation and its prevention in acute pancreatitisJournal of Hepato-Biliary-Pancreatic Surgery, 2003
- Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitisNeurogastroenterology & Motility, 2003
- The Role of Interdigestive Small Bowel Motility in the Regulation of Gut Microflora, Bacterial Overgrowth, and Bacterial Translocation in RatsAnnals of Surgery, 1998